Galvani Bioelectronics

Stevenage, United Kingdom Founded: 2016 • Age: 10 yrs
Implantable neuromodulation devices for chronic disease treatment are developed.
Annual revenue - Latest available
Total funding - 4 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 2 Services tracked
Competitors 9 Brand Intelligence

About Galvani Bioelectronics

Galvani Bioelectronics is a company based in Stevenage (United Kingdom) founded in 2016. Galvani Bioelectronics offers products and services including Neuromodulation System and Splenic Nerve Stimulation. Galvani Bioelectronics operates in a competitive market with competitors including NeuroMetrix, Remedee Labs, Sky Medical Technology, Electromedical Technologies and Enso Relief, among others.

  • Headquarter Stevenage, United Kingdom
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Galvani Bioelectronics Limited
  • Date of Incorporation 03 Feb, 2016
  • Jurisdiction STEVENAGE, UNITED KINGDOM
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Galvani Bioelectronics

Galvani Bioelectronics offers a comprehensive portfolio of products and services, including Neuromodulation System and Splenic Nerve Stimulation.

Product name locked
Category locked
Primary

Technology for precision therapy in rheumatoid arthritis treatment.

Product name locked
Category locked
Locked

System to modulate immune responses for disease management.

People of Galvani Bioelectronics

Headcount 10-50
Employee Profiles 18
Board Members and Advisors 5
Employee Profiles
People
Firat Yazicioglu
Chief Product And Technology Officer
People
Kristoffer Famm
President & CEO
People
Adam Roth
Vice President Of Business Operations
People
Morten Hansen
Director Of Surgical Development

Unlock access to complete

Board Members and Advisors
people
Ken Gabriel
Director
people
Subesh Williams
Director
people
Christopher Corsico
Chair
people
Brad Hirsch
Director

Unlock access to complete

Funding Insights of Galvani Bioelectronics

Investors in Galvani Bioelectronics

Galvani Bioelectronics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Premium access

Investor details for Galvani Bioelectronics

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Galvani Bioelectronics

Investments
Premium access

Investment portfolio details for Galvani Bioelectronics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Galvani Bioelectronics

Premium access

Detailed financials for Galvani Bioelectronics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Galvani Bioelectronics Comparisons

Galvani Bioelectronics Primary company
Description
Implantable neuromodulation devices for chronic disease trea...
Location
Stevenage, United Kingdom
Founded Year
2016
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Galvani Bioelectronics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Galvani Bioelectronics

Galvani Bioelectronics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuroMetrix, Remedee Labs, Sky Medical Technology, Electromedical Technologies and Enso Relief, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Wearable technology for pain, nerve disease and sleep disorders
Locked Locked Locked
Endorphin stimulation therapy for pain management is developed.
Locked Locked Locked
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
Locked Locked Locked
An electrotherapy device that helps reduce and eliminate chronic or acute pain
Locked Locked Locked
A wearable neuromodulation device for pain relief is developed.
Premium access

Detailed competitors of Galvani Bioelectronics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Galvani Bioelectronics

Premium access

Complete news archive for Galvani Bioelectronics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Galvani Bioelectronics

Galvani Bioelectronics was founded in 2016.

Galvani Bioelectronics is headquartered in Stevenage, United Kingdom. It is registered at Stevenage, Hertfordshire, United Kingdom.

Galvani Bioelectronics was established in 2016 as a joint venture between GSK and Verily Life Sciences, based in Stevenage, United Kingdom. Focus is placed on bioelectronic medicines through miniaturized, low-power implantable devices that deliver neuromodulation therapy via electrical nerve signals. Operations include data analytics and software development tailored for clinical applications in treating chronic conditions.

Galvani Bioelectronics's top competitors include Remedee Labs, Sky Medical Technology and Electromedical Technologies.

Galvani Bioelectronics offers Neuromodulation System and Splenic Nerve Stimulation.

Galvani Bioelectronics has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available